Gene Query: TNIP2

Dataset Description Geneva Score
Mapping interactions for the TNIP2 hub protein 59.15
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 24.59
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 20.75
Primary Human B-cell Temporal Response to CD40L Stimulation 18.77
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 17.77
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 16.96
METTL3 promotes translation in human cancer cells 16.49
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.73
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.73
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 13.63
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 12.51
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 12.51
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 12.49
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 12.49
Neonatal and adult human testis defined at the single-cell level 12.17
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 11.99
Selective suppression of endothelial cytokine production by progesterone receptor 11.99
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 11.94
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.94
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 11.9
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 11.9
ARID1A regulates condensin II distribution and chromosomal partition 11.9
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.34
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 11.3
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 11.21
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 11.1
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 10.71
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 10.69
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 10.69
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 10.59
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.48
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.48
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 10.35
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 10.0
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 9.79
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.7
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.47
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 9.31
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.86
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.86
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 8.65
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 8.5
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 8.5
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.33
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.33
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.16
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 8.02
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.01
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.01
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 7.9
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 7.9
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 7.9
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.63
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.59
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.53
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 7.53
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 7.45
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 7.45
The evolution of N6-methyladenosine in primates 7.26
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.26
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 6.98
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 6.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.92
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.92
Ro60-knockout cells 6.82
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.79
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 6.72
Trans-differentiation of human adult peripheral blood T cells into neurons 6.66
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.63
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.61
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 6.53
RNAseq of HEK293 cells after Chtop knockdown 6.47
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.47
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.47
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.43
ZIKV infection of monocytes activates inflammasome pathways 6.41
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.31
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.3
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.19
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 6.14
RNA sequencing of GlyH-101-treated MCF-7 cell line 6.14
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.13
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 6.08
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 6.0
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.85
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.83
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 5.82
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.7
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 5.58
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.52
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.49
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.44
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.36
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.3
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 5.29
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 5.29
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.29
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.27
Gene expression in PANC1 cells treated with Rakicidin 5.24
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.21
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.14
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 5.13
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 5.13
CROP-Seq in Primary Human T Cells 5.06
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 5.05
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.05
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 5.03
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 5.03
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.03
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 5.01
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.0
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 4.97
The comparison of high-throughput single-cell RNA-seq methods 4.97
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.89
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.87
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.87
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.86
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.81
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.79
Stem and effector CD8 T-cells from human cancers 4.73
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.69
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.69
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 4.69
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.68
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.63
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.62
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.52
Noncoding regions are the main source of targetable tumor-specific antigens 4.5
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.49
Fbxo32 mediated gene expression program underlies EMT and metastasis 4.48
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.44
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.44
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.44
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 4.43
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 4.43
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 4.4
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 4.37
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.36
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.34
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.28
SNHG5 siRNA knock down in HCT116 cells 4.28
Single-cell analysis of adult human ovary using 10X genomics 4.28
Effects of rFVIIIFc on human macrophages 4.28
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.25
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.24
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.23
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.22
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 4.22
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 4.14
IMP3 regulated gene expression in breast cancer cells 4.12
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.11
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.11
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.08
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.07
Cajal bodies are linked to genome conformation 4.03
Cajal bodies are linked to genome conformation [RNA-Seq] 4.03
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 4.02
Landscape and variation of RNA secondary structure across the human transcriptome 4.02
RNA-seq of naive and primed ES cells 4.0
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.0
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 3.99
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.99
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 3.94
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 3.93
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.92
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.9
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 3.89
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.87
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 3.86
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.84
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.83
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.79
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.76
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.76
The cytokine environment influence on human skin-derived T cells 3.76
Patient-derived luminal breast cancer xenografts with progestins 3.68
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 3.68
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.68
Targeting MTHFD2 in Acute Myeloid Leukemia 3.67
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.66
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.66
Human Treg NaCl stimulation 3.63
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 3.61
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.61
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.6
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.58
PRDM1 inhibits proliferation of human colon cancer organoids 3.54
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.52
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.49
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.49
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.48
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.46
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.45
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.44
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.42
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.42
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.42
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.41
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.38
RNA-seq of RKO cells with cTAZ KO or putback 3.37
Effect of Influenza virus infection on lncRNA expression in A549 cells 3.36
RNA-seq analysis of control and Myc-induced U2OS cells 3.36
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 3.33
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 3.3
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 3.3
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 3.29
Seletive inhibition of CDK9 in DLBCL cell lines 3.28
Global analysis of alternative splicing regulated by RBM10 3.28
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 3.28
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 3.28
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 3.27
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 3.27
Total RNA sequencing of WT intestinal orgaonids. 3.26
Regulation of highly expressed hCINAP on translatome 3.25
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 3.23
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.22
miR941 overexpression experiment 3.22
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 3.21
oxLDL exposed trained monocytes 3.21
Transcriptomes of oxLDL exposed trained monocytes 3.21
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 3.2
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.19
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.15
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.15
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.15
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.15
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.14
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.13
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 3.11
Gene expression in GBM with Cav3.2 inhibition 3.1
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.09
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.01
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.01
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.99
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.98
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.97
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.96
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.93
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.93
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.91
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.91
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.91
NAPRT activation of macrophages 2.85
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 2.85
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 2.85
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.82
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.77
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.75
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.74
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 2.74
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.72
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.72
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.69
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.69
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 2.68
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 2.68
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.68
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.65
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.63
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.59
RNA-seq of YB5 cells treated with Proscillaridin A 2.59
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.57
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.57
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.57
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.57
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.56
IRF2 is a master regulator of human keratinocyte stem cell fate 2.56
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.55
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.54
Global Mapping of Human RNA-RNA Interactions 2.53
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.52
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.5
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.5
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 2.5
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 2.48
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.47
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.45
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.43
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 2.42
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 2.42
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.41
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 2.35
Iron response of HepG2 cells 2.35
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.35
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.35
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.34
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.33
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.32
Dermal endothelial cells of type 2 diabetic patients 2.28
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.26
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.23
X-Ray induced DNA-Hydroxymethylation changes 2.22
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.2
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.19
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.19
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 2.15
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.14
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.14
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.13
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.12
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.09
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.07
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.02
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.02
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.01
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.0
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.0
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.99
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.99
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.97
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.95
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.95
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.93
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.91
Functional role of CPPED1 in trophoblasts. 1.91
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.9
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.9
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.85
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.85
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.83
Hepatocyte maturation 1.82
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.82
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.79
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.78
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.76
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.75
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.75
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.73
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.73
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.73
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.72
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.71
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.71
The cohesin complex prevents Myc-induced replication stress 1.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.67
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.65
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.65
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.63
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.61
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.61
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.59
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.57
Molecular Criteria for Defining the Naive Human Pluripotent State 1.56
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.56
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.56
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.55
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.54
RNA editing in nascent RNA affects pre-mRNA splicing 1.52
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.5
RNAseq of cell lines with knocked in ESR1 mutations 1.5
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.49
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.49
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.47
Real-time observation of light-controlled transcription in living cells 1.46
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.44
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.43
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.43
miRNAs affected by antagomiR-17 treatment 1.37
Characterization of human ILC2 subsets 1.35
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.33
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.33
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.32
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.31
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.29
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.28
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.27
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.27
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.27
RNA-seq analysis upon ARID1B overexpression 1.26
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.26
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.26
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.26
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.24
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.22
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.2
FBXW7 modulates stress response by post-translational modification of HSF1 1.19
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.19
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.19
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.18
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.17
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.15
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.13
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.13
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.13
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.12
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.12
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.12
MHC Transcriptomic landscape at haplotype-specific resolution 1.1
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.09
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.09
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.05
AMPK signaling for naïve pluripotency [Hs] 1.04
AMPK signaling for naïve pluripotency 1.04
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.03
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.02
CD86 regulates a pro-survival signal in myeloma cells 1.01
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.01
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.0
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.98
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 0.96
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.96
miR-93 Targets in Human Endothelial Cells 0.94
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.93
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.93
Functional significance of the HIV-1 Tat signature amino acid residues 0.93
Tpl-2 and MEK small molecule inhibitors 0.92
Tpl-2 small molecule project 0.92
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.92
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.92
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.89
MARCKS and lnc-MARCKS act as inflammation regulators 0.88
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.86
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.86
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.85
Oncogenic roles of ARID5B in T-ALL 0.85
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.85
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.85
KLF6-dependent transcription in renal cancer cells 0.79
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.78
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.77
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.76
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.75
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.74
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.72
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.71
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.68
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.68
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.67
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.66
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.65
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.65
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.65
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.64
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.63
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.63
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.63
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.63
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.63
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.61
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.61
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.6
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.59
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.55
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.54
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.54
Anti-inflammatory effect of indoleacrylic acid (IA) 0.54
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.53
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.53
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.52
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.5
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.49
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.47
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.47
Polarized B -cell functions 0.45
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.43
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.4
BACH2 in human plasma cell fate decision 0.4
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.38
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.37
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.36
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.32
Transcriptional profile in human S. haematobium infection 0.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.29
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.29
The role of m6A/m-RNA methylation in stress response regulation 0.28
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.28
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.28
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.27
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.25
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.24
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 0.24
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.22
Human Treg IFNg/IL-10 subpopulations 0.22
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.22
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.21
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.21
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.21
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.21
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.2
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.16
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.16
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.13
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.11
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.11
Myc activation coordinates gene transcription and protein translation responses 0.08
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 0.08
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.07
Expression profiling of converted and control dermal BJ fibroblasts 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
siRNA-mediated knockdown 0.06
The transcriptome and chromatin accessbility landscape of mammalian germline 0.06
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.05
Transcriptomic analysis of human macrophages in 3D 0.04
Transcriptomic analysis of LSD1 0.02
H1609088 Human RNA-Sequencing 0.02
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation